Fundraising Fox
Kuros Biosciences
216 employees on LinkedIn · 2 known investors
Find your way into Kuros Biosciences
Sign up to see every warm intro you have to Kuros Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kuros Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications. Originally a spin-off of the Swiss Federal Institute of Technology in Zurich, it is publicly listed on the SIX Swiss Stock Exchange and operates in Switzerland, the Netherlands, and the USA.
Founders & leadership
CF
Chris FairCEOChris Fair is CEO of Kuros Biosciences, a Swiss biotech company developing bone healing technologies for orthopedic surgery. He has held executive positions in the medical device industry and studied business administration at the University of Richmond.
Investors · 2
In the news
Frequently asked questions
- What does Kuros Biosciences do?
- Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications. Originally a spin-off of the Swiss Federal Institute of Technology in Zurich, it is publicly listed on the SIX Swiss Stock Exchange and operates in Switzerland, the Netherlands, and the USA.
- Who are Kuros Biosciences's investors?
- Kuros Biosciences's investors include Daniel Gutenberg, VI Partners.